New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Rare Failed Drug Test for Horse Trained by McAnallyon May 17, 2021 at 2:41 pm
The California Horse Racing Board filed a complaint against Racing Hall of Fame trainer Ron McAnally after his runner Roses and Candy failed a post-race drug test after she finished first in a starter ...
- CHRB Files Medication Complaints Against Hall Of Famers McAnally, Mandellaon May 17, 2021 at 2:26 pm
The California Horse Racing Board has filed medication complaints against trainers Ron McAnally and Richard Mandella, two members of the National Museum of Racing and Hall of Fame who have rarely been ...
- CBD Has Never Been A Controlled Substanceon May 16, 2021 at 1:10 pm
Was it ever a controlled substance? How is it regulated? Lawyers, industry professionals, and learned scholars debate this with so much vigor that it creates confusion, if not a misstatement of the ...
- Cannabis firms should watch the health benefits claims, else face sanction, analysts sayon May 14, 2021 at 11:47 am
CannaCraft’s $300,000 deal to end a California lawsuit about the benefits of non-hallucinogenic CBD should inform companies to rigorously document such statements.
- 11 CBD facts every CBD user should knowon May 13, 2021 at 8:09 am
There is no doubt that you will have heard about CBD in the last few years. The health craze is certainly taking the wellness industry by storm.
- Sore Muscles or Back Pain? Use This Best CBD Cream For Pain Reliefon May 13, 2021 at 5:52 am
We sampled a range of different products to discover the best CBD creams for pain relief; specifically, pain stemming from arthritis, joint pains, migraines, and muscle cramps. Especially severe pain ...
- Cannabidiol Market Stock, Growth Competitive Insights, Demand and Rising Trends till 2027on May 13, 2021 at 4:43 am
The global cannabidiol market size is expected to reach USD 39.99 billion by 2027, exhibiting an excellent CAGR of ...
- Cannabidiol (CBD) Market latest Trends and New Technologies Research Forecast to 2026on May 10, 2021 at 11:03 pm
The latest report on Cannabidiol (CBD) market aims to help businesses, marketers, and other stakeholders grasp a better understanding of the growth drivers of this industry and capitalize on the ...
- Glasgow's luxury Blythswood Square hotel to offer novel 'nature' sleepovers and cannabidiol cocktails for well-being tourists after lockdownon May 10, 2021 at 9:46 am
A Scottish hotel has launched a special new ‘green’ room offering guests a chance to get closer to nature while simultaneously enjoying luxury on tap.
via Bing News